ITH Pharma specialises in the provision of of aseptic compounding services for all therapy areas - particularly Parenteral Nutrition, Chemotherapy and CIVAS.
The company was launched in October 2008 by the founding members of Intra-Tech Healthcare, so although we're new, we are experienced and have the understanding of what you require from a supplier.
Our team leads the industry in innovation, providing flexible, cost effective services with both batch and bespoke items for adults, paediatrics and neonates.
Revenue (FY, 2016)
Revenue growth (FY, 2015 - FY, 2016), %
Gross profit (FY, 2016)
Gross profit margin (FY, 2016), %
Net income (FY, 2016)
EBITDA (FY, 2016)
EBIT (FY, 2016)
|GBP||FY, 2011||FY, 2012||FY, 2013||FY, 2014||FY, 2015||FY, 2016|
|34.1 k||335 k||547.1 k||947.3 k||282.2 k||494.6 k|
Cash From Operating Activities
|(198.5 k)||412.8 k||148.6 k||605.7 k||799.8 k||276.4 k|
Cash From Financing Activities
|262.9 k||(160.2 k)||(305.9 k)||(1.1 m)|
Net Change in Cash
|(118 k)||88.9 k||(101.8 k)||(744.2 k)||447.4 k||(739.7 k)|